Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Coronavirus: Food that can inhibit COVID-19, according to a study
While the novel coronavirus continues to disrupt the lives of people, new researches are being done everyday to contain the deadly virus.
Robot Inoculators Accelerate China’s Vaccine Rollout
SHANGHAI — As China begins rolling out its COVID-19 vaccines, the country is trialling an unconventional approach to speed up the program.
Moderna on track to report COVID-19 vaccine data later this month
(Reuters) - Moderna Inc said on Wednesday it was on track to report early data from a late-stage trial of its experimental coronavirus vaccine later this month, and could file for U.
Novartis arthritis drug fails to help COVID-19 patients
ZURICH (Reuters) - Novartis's NOVN.
BYU blood test can detect presence of deadly superbugs in less than one hour
If you have antibiotic-resistant bacteria in your blood, you need to know pretty quick what’s going on in there.
An Amazonian tea stimulates the formation of new neurons
One of the main natural components of ayahuasca tea is dimethyltryptamine (DMT), which promotes neurogenesis —the formation of new neurons—according to research led by the Complutense Univ...
Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases
Researchers from the Institut national de la recherche scientifique (INRS) have shown that nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases.
Pfizer Soars as Vaccine Prevents 90% of Covid Cases in Study
A vaccine developed by Pfizer Inc.
FDA Authorizes Monoclonal Antibody for Treatment of COVID-19
Today, the U.
Novo Nordisk lays out $1.8B for Emisphere and its oral delivery tech
Danish drugmaker Novo Nordisk made waves last year with the approval of its oral diabetes med Rybelsus.
Regeneron predicts 300,000 COVID-19 cocktail doses ready by January, and 'substantially more' in 2021
Like many of its peers, Regeneron responded swiftly to the COVID-19 pandemic and moved treatment candidates quickly through testing.
Japan's Takeda eyes new focus on vaccines after OTC asset sales - CEO
TOKYO (Reuters) - Japan’s Takeda Pharmaceutical Co is looking at making vaccines a core business after completing asset sales to lower debt following its takeover of Shire Plc, Chief Executi...
293
294
295
296
297
298
299
300
301